BACKGROUND: Relative telomere length in peripheral blood leukocytes has been evaluated as a potential biomarker for renal cell carcinoma (RCC) risk in several studies, with conflicting findings. OBJECTIVE: We performed an analysis of genetic variants associated with leukocyte telomere length to assess the relationship between telomere length and RCC risk using Mendelian randomization, an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations. DESIGN, SETTING, AND PARTICIPANTS: Genotypes from nine telomere length-associated variants for 10 784 cases and 20 406 cancer-free controls from six genome-wide association studies (GWAS) of RCC were aggregated into a weighted genetic risk score (GRS) predictive of leukocyte telomere length. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Odds ratios (ORs) relating the GRS and RCC risk were computed in individual GWAS datasets and combined by meta-analysis. RESULTS AND LIMITATIONS: Longer genetically inferred telomere length was associated with an increased risk of RCC (OR=2.07 per predicted kilobase increase, 95% confidence interval [CI]:=1.70-2.53, p<0.0001). As a sensitivity analysis, we excluded two telomere length variants in linkage disequilibrium (R2>0.5) with GWAS-identified RCC risk variants (rs10936599 and rs9420907) from the telomere length GRS; despite this exclusion, a statistically significant association between the GRS and RCC risk persisted (OR=1.73, 95% CI=1.36-2.21, p<0.0001). Exploratory analyses for individual histologic subtypes suggested comparable associations with the telomere length GRS for clear cell (N=5573, OR=1.93, 95% CI=1.50-2.49, p<0.0001), papillary (N=573, OR=1.96, 95% CI=1.01-3.81, p=0.046), and chromophobe RCC (N=203, OR=2.37, 95% CI=0.78-7.17, p=0.13). CONCLUSIONS: Our investigation adds to the growing body of evidence indicating some aspect of longer telomere length is important for RCC risk. PATIENT SUMMARY: Telomeres are segments of DNA at chromosome ends that maintain chromosomal stability. Our study investigated the relationship between genetic variants associated with telomere length and renal cell carcinoma risk. We found evidence suggesting individuals with inherited predisposition to longer telomere length are at increased risk of developing renal cell carcinoma.

1st Faculty of Medicine Institute of Hygiene and Epidemiology Charles University Prague Czech Republic

2nd Faculty of Medicine Institute of Public Health and Preventive Medicine Charles University Prague Czech Republic

American Cancer Society Atlanta GA USA

AP HP Department of Urology Hopitaux Universitaires Est Parisien Tenon Paris France

Brigham and Women's Hospital Boston MA USA

Brown University Providence RI USA

Cancer Epidemiology and Intelligence Division Cancer Council Victoria Melbourne Australia

Carol Davila University of Medicine and Pharmacy Th Burghele Hospital Bucharest Romania

Center 'Bioengineering' of the Russian Academy of Sciences Moscow Russian Federation

Centre de Recherche en Épidémiologie et Santé des Populations Université Paris Saclay UPS USQ Gustave Roussy Villejuif France

Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health The University of Melbourne Carlton Australia

Centre National de Recherche en Genomique Humaine Institut de biologie François Jacob Commissariat à l'Energie Atomique et aux Energies Alternatives Evry France

CeRePP Paris France

Clinic for Nephrology Military Medical Academy Belgrade Serbia

CNRS UMR8200 Institute Gustave Roussy Villejuif France

College of Human Medicine Michigan State University Grand Rapids MI USA

Dana Farber Cancer Institute Boston MA USA

Department for Determinants of Chronic Diseases Bilthoven The Netherlands

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic

Department of Epidemiology and Biostatistics School of Public Health Indiana University Bloomington Bloomington IN USA

Department of Epidemiology and Biostatistics The School of Public Health Imperial College London St Mary's Campus Norfolk Place London UK

Department of Epidemiology Division of Cancer Prevention and Population Sciences The University of Texas MD Anderson Cancer Center Houston TX USA

Department of Epidemiology Institute of Occupational Medicine Lodz Poland

Department of Gastroenterology and Hepatology University Medical Centre Utrecht The Netherlands

Department of Oncology and Department of Public Health and Primary Care University of Cambridge Cambridge UK

Department of Preventive Medicine Faculty of Medicine Palacky University Czech Republic

Department of Public Health and General Practice Faculty of Medicine Norwegian University of Science and Technology Trondheim Norway

Department of Social and Preventive Medicine Faculty of Medicine University of Malaya Pantai Valley Kuala Lumpur Malaysia

Department of Surgical and Perioperative Sciences Urology and Andrology Umeå University Umeå Sweden

Department of Urology The University of Texas MD Anderson Cancer Center Houston TX USA

Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Department Health and Human Services Bethesda MS USA

Division of Urology Spectrum Health Grand Rapids MI USA

Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain Paris France

Fred Hutchinson Cancer Research Center Seattle WA USA

Genomic Epidemiology Group German Cancer Research Center Heidelberg Germany

Harvard T H Chan School of Public Health Boston MA USA

Human Genetics Foundation Torino Italy

HUNT Research Centre Department of Public Health and General Practice Norwegian University of Science and Technology Levanger Sweden

Icahn School of Medicine New York NY USA

INSERM U946 Paris France

Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

International Agency for Research on Cancer Lyon France

International Hereditary Cancer Center Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland

International Organization for Cancer Prevention and Research Belgrade Serbia

Kurchatov Scientific Center Moscow Russian Federation

Leeds Institute of Cancer and Pathology University of Leeds Cancer Research Building St James's University Hospital Leeds UK

London School of Hygiene and Tropical Medicine University of London London UK

McGill University and Genome Quebec Innovation Centre Montreal QC Canada

National Institute for Health and Welfare Helsinki Finland

National Institute of Public Health Bucharest Romania

National Public Health Center National Directorate of Environmental Health Budapest Hungary

QIMR Berghofer Medical Research Institute Herston Queensland Australia

Regional Authority of Public Health in Banska Bystrica Banska Bystrica Slovakia

Royal Marsden NHS Foundation Trust London UK

Russian N N Blokhin Cancer Research Centre Moscow Russian Federation

School of Public Health The University of Queensland Brisbane Australia

St Jude Children's Research Hospital Memphis TN USA

The Institute of Cancer Research London UK

The M Sklodowska Curie Cancer Center and Institute of Oncology Warsaw Poland

Unit of Nutrition and Cancer Cancer Epidemiology Research Program Catalan Institute of Oncology Barcelona Spain

University of Cambridge Cambridge UK

UPMC Univ Paris 06 Institut Universitaire de Cancérologie Paris France

Van Andel Research Institute Center for Cancer Genomics and Quantitative Biology Grand Rapids MI USA

Vanderbilt Ingram Cancer Center Nashville TN USA

Veterans Administration Boston MA USA

000      

00000naa a2200000 a 4500

001      

bmc18024747

003      

CZ-PrNML

005      

20180710095250.0

007      

ta

008      

180709s2017 sz f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.eururo.2017.07.015 $2 doi

035    __

$a (PubMed)28797570

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Machiela, Mitchell J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

245    10

$a Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma / $c MJ. Machiela, JN. Hofmann, R. Carreras-Torres, KM. Brown, M. Johansson, Z. Wang, M. Foll, P. Li, N. Rothman, SA. Savage, V. Gaborieau, JD. McKay, Y. Ye, M. Henrion, F. Bruinsma, S. Jordan, G. Severi, K. Hveem, LJ. Vatten, T. Fletcher, K. Koppova, SC. Larsson, A. Wolk, RE. Banks, PJ. Selby, DF. Easton, P. Pharoah, G. Andreotti, LEB. Freeman, S. Koutros, D. Albanes, S. Mannisto, S. Weinstein, PE. Clark, TE. Edwards, L. Lipworth, SM. Gapstur, VL. Stevens, H. Carol, ML. Freedman, MM. Pomerantz, E. Cho, P. Kraft, MA. Preston, KM. Wilson, JM. Gaziano, HS. Sesso, A. Black, ND. Freedman, WY. Huang, JG. Anema, RJ. Kahnoski, BR. Lane, SL. Noyes, D. Petillo, LM. Colli, JN. Sampson, C. Besse, H. Blanche, A. Boland, L. Burdette, E. Prokhortchouk, KG. Skryabin, M. Yeager, M. Mijuskovic, M. Ognjanovic, L. Foretova, I. Holcatova, V. Janout, D. Mates, A. Mukeriya, S. Rascu, D. Zaridze, V. Bencko, C. Cybulski, E. Fabianova, V. Jinga, J. Lissowska, J. Lubinski, M. Navratilova, P. Rudnai, N. Szeszenia-Dabrowska, S. Benhamou, G. Cancel-Tassin, O. Cussenot, HB. Bueno-de-Mesquita, F. Canzian, EJ. Duell, B. Ljungberg, RT. Sitaram, U. Peters, E. White, GL. Anderson, L. Johnson, J. Luo, J. Buring, IM. Lee, WH. Chow, LE. Moore, C. Wood, T. Eisen, J. Larkin, TK. Choueiri, GM. Lathrop, BT. Teh, JF. Deleuze, X. Wu, RS. Houlston, P. Brennan, SJ. Chanock, G. Scelo, MP. Purdue,

520    9_

$a BACKGROUND: Relative telomere length in peripheral blood leukocytes has been evaluated as a potential biomarker for renal cell carcinoma (RCC) risk in several studies, with conflicting findings. OBJECTIVE: We performed an analysis of genetic variants associated with leukocyte telomere length to assess the relationship between telomere length and RCC risk using Mendelian randomization, an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations. DESIGN, SETTING, AND PARTICIPANTS: Genotypes from nine telomere length-associated variants for 10 784 cases and 20 406 cancer-free controls from six genome-wide association studies (GWAS) of RCC were aggregated into a weighted genetic risk score (GRS) predictive of leukocyte telomere length. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Odds ratios (ORs) relating the GRS and RCC risk were computed in individual GWAS datasets and combined by meta-analysis. RESULTS AND LIMITATIONS: Longer genetically inferred telomere length was associated with an increased risk of RCC (OR=2.07 per predicted kilobase increase, 95% confidence interval [CI]:=1.70-2.53, p<0.0001). As a sensitivity analysis, we excluded two telomere length variants in linkage disequilibrium (R2>0.5) with GWAS-identified RCC risk variants (rs10936599 and rs9420907) from the telomere length GRS; despite this exclusion, a statistically significant association between the GRS and RCC risk persisted (OR=1.73, 95% CI=1.36-2.21, p<0.0001). Exploratory analyses for individual histologic subtypes suggested comparable associations with the telomere length GRS for clear cell (N=5573, OR=1.93, 95% CI=1.50-2.49, p<0.0001), papillary (N=573, OR=1.96, 95% CI=1.01-3.81, p=0.046), and chromophobe RCC (N=203, OR=2.37, 95% CI=0.78-7.17, p=0.13). CONCLUSIONS: Our investigation adds to the growing body of evidence indicating some aspect of longer telomere length is important for RCC risk. PATIENT SUMMARY: Telomeres are segments of DNA at chromosome ends that maintain chromosomal stability. Our study investigated the relationship between genetic variants associated with telomere length and renal cell carcinoma risk. We found evidence suggesting individuals with inherited predisposition to longer telomere length are at increased risk of developing renal cell carcinoma.

650    _2

$a karcinom z renálních buněk $x krev $x genetika $x patologie $7 D002292

650    _2

$a studie případů a kontrol $7 D016022

650    _2

$a genetická predispozice k nemoci $7 D020022

650    _2

$a celogenomová asociační studie $7 D055106

650    _2

$a lidé $7 D006801

650    _2

$a nádory ledvin $x krev $x genetika $x patologie $7 D007680

650    _2

$a leukocyty $x chemie $7 D007962

650    _2

$a mendelovská randomizace $7 D057182

650    _2

$a odds ratio $7 D016017

650    _2

$a fenotyp $7 D010641

650    12

$a jednonukleotidový polymorfismus $7 D020641

650    _2

$a hodnocení rizik $7 D018570

650    _2

$a rizikové faktory $7 D012307

650    _2

$a telomery $x genetika $x patologie $7 D016615

650    12

$a homeostáza telomer $7 D059505

655    _2

$a časopisecké články $7 D016428

655    _2

$a metaanalýza $7 D017418

655    _2

$a multicentrická studie $7 D016448

655    _2

$a Research Support, N.I.H., Intramural $7 D052060

655    _2

$a práce podpořená grantem $7 D013485

655    _2

$a Research Support, N.I.H., Extramural $7 D052061

700    1_

$a Hofmann, Jonathan N $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Carreras-Torres, Robert $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Brown, Kevin M $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Johansson, Mattias $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Wang, Zhaoming $u St. Jude Children's Research Hospital, Memphis, TN, USA.

700    1_

$a Foll, Matthieu $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Li, Peng $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Rothman, Nathaniel $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Savage, Sharon A $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Gaborieau, Valerie $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a McKay, James D $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Ye, Yuanqing $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

700    1_

$a Henrion, Marc $u Icahn School of Medicine, New York, NY, USA.

700    1_

$a Bruinsma, Fiona $u Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.

700    1_

$a Jordan, Susan $u QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Brisbane, Australia.

700    1_

$a Severi, Gianluca $u Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia; Human Genetics Foundation (HuGeF), Torino, Italy; Centre de Recherche en Épidémiologie et Santé des Populations, Université Paris-Saclay, UPS, USQ, Gustave Roussy, Villejuif, France.

700    1_

$a Hveem, Kristian $u HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Sweden.

700    1_

$a Vatten, Lars J $u Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

700    1_

$a Fletcher, Tony $u London School of Hygiene and Tropical Medicine, University of London, London, UK.

700    1_

$a Koppova, Kvetoslava $u Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.

700    1_

$a Larsson, Susanna C $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

700    1_

$a Wolk, Alicja $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

700    1_

$a Banks, Rosamonde E $u Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.

700    1_

$a Selby, Peter J $u Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.

700    1_

$a Easton, Douglas F $u Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

700    1_

$a Pharoah, Paul $u Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

700    1_

$a Andreotti, Gabriella $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Freeman, Laura E Beane $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Koutros, Stella $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Albanes, Demetrius $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Mannisto, Satu $u National Institute for Health and Welfare, Helsinki, Finland.

700    1_

$a Weinstein, Stephanie $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Clark, Peter E $u Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.

700    1_

$a Edwards, Todd E $u Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.

700    1_

$a Lipworth, Loren $u Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.

700    1_

$a Gapstur, Susan M $u American Cancer Society, Atlanta, GA, USA.

700    1_

$a Stevens, Victoria L $u American Cancer Society, Atlanta, GA, USA.

700    1_

$a Carol, Hallie $u Dana-Farber Cancer Institute, Boston, MA, USA.

700    1_

$a Freedman, Matthew L $u Dana-Farber Cancer Institute, Boston, MA, USA.

700    1_

$a Pomerantz, Mark M $u Dana-Farber Cancer Institute, Boston, MA, USA.

700    1_

$a Cho, Eunyoung $u Brown University, Providence, RI, USA.

700    1_

$a Kraft, Peter $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.

700    1_

$a Preston, Mark A $u Brigham and Women's Hospital, Boston, MA, USA.

700    1_

$a Wilson, Kathryn M $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.

700    1_

$a Gaziano, J Michael $u Brigham and Women's Hospital, Boston, MA, USA; Veterans Administration, Boston, MA, USA.

700    1_

$a Sesso, Howard S $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.

700    1_

$a Black, Amanda $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Freedman, Neal D $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Huang, Wen-Yi $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Anema, John G $u Division of Urology, Spectrum Health, Grand Rapids, MI, USA.

700    1_

$a Kahnoski, Richard J $u Division of Urology, Spectrum Health, Grand Rapids, MI, USA.

700    1_

$a Lane, Brian R $u Division of Urology, Spectrum Health, Grand Rapids, MI, USA; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.

700    1_

$a Noyes, Sabrina L $u Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.

700    1_

$a Petillo, David $u Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.

700    1_

$a Colli, Leandro M $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Sampson, Joshua N $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Besse, Celine $u Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France.

700    1_

$a Blanche, Helene $u Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.

700    1_

$a Boland, Anne $u Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France.

700    1_

$a Burdette, Laurie $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Prokhortchouk, Egor $u Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation; Kurchatov Scientific Center, Moscow, Russian Federation.

700    1_

$a Skryabin, Konstantin G $u Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation; Kurchatov Scientific Center, Moscow, Russian Federation.

700    1_

$a Yeager, Meredith $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Mijuskovic, Mirjana $u Clinic for Nephrology, Military Medical Academy, Belgrade, Serbia.

700    1_

$a Ognjanovic, Miodrag $u International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.

700    1_

$a Foretova, Lenka $u International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.

700    1_

$a Holcatova, Ivana $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

700    1_

$a Janout, Vladimir $u Second Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic.

700    1_

$a Mates, Dana $u Department of Preventive Medicine, Faculty of Medicine, Palacky University, Czech Republic.

700    1_

$a Mukeriya, Anush $u National Institute of Public Health, Bucharest, Romania.

700    1_

$a Rascu, Stefan $u Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.

700    1_

$a Zaridze, David $u National Institute of Public Health, Bucharest, Romania.

700    1_

$a Bencko, Vladimir $u Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.

700    1_

$a Cybulski, Cezary $u First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.

700    1_

$a Fabianova, Eleonora $u Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.

700    1_

$a Jinga, Viorel $u Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.

700    1_

$a Lissowska, Jolanta $u The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.

700    1_

$a Lubinski, Jan $u International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

700    1_

$a Navratilova, Marie $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

700    1_

$a Rudnai, Peter $u National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary.

700    1_

$a Szeszenia-Dabrowska, Neonila $u Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland.

700    1_

$a Benhamou, Simone $u INSERM U946, Paris, France; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.

700    1_

$a Cancel-Tassin, Geraldine $u CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France.

700    1_

$a Cussenot, Olivier $u CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France; AP-HP, Department of Urology, Hopitaux Universitaires Est Parisien Tenon, Paris, France.

700    1_

$a Bueno-de-Mesquita, H Bas $u Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, Kuala Lumpur, Malaysia.

700    1_

$a Canzian, Federico $u Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

700    1_

$a Duell, Eric J $u Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

700    1_

$a Ljungberg, Börje $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.

700    1_

$a Sitaram, Raviprakash T $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.

700    1_

$a Peters, Ulrike $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

700    1_

$a White, Emily $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

700    1_

$a Anderson, Garnet L $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

700    1_

$a Johnson, Lisa $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

700    1_

$a Luo, Juhua $u Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, IN, USA.

700    1_

$a Buring, Julie $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.

700    1_

$a Lee, I-Min $u Harvard T.H. Chan School of Public Health, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.

700    1_

$a Chow, Wong-Ho $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

700    1_

$a Moore, Lee E $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Wood, Christopher $u Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

700    1_

$a Eisen, Timothy $u University of Cambridge, Cambridge, UK.

700    1_

$a Larkin, James $u Royal Marsden NHS Foundation Trust, London, UK.

700    1_

$a Choueiri, Toni K $u Dana-Farber Cancer Institute, Boston, MA, USA.

700    1_

$a Lathrop, G Mark $u McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada.

700    1_

$a Teh, Bin Tean $u Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.

700    1_

$a Deleuze, Jean-Francois $u Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France; Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.

700    1_

$a Wu, Xifeng $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

700    1_

$a Houlston, Richard S $u The Institute of Cancer Research, London, UK.

700    1_

$a Brennan, Paul $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Chanock, Stephen J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.

700    1_

$a Scelo, Ghislaine $u International Agency for Research on Cancer (IARC), Lyon, France.

700    1_

$a Purdue, Mark P $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA. Electronic address: purduem@mail.nih.gov.

773    0_

$w MED00001669 $t European urology $x 1873-7560 $g Roč. 72, č. 5 (2017), s. 747-754

856    41

$u https://pubmed.ncbi.nlm.nih.gov/28797570 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20180709 $b ABA008

991    __

$a 20180710095539 $b ABA008

999    __

$a ok $b bmc $g 1316878 $s 1021668

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2017 $b 72 $c 5 $d 747-754 $e 20170807 $i 1873-7560 $m European urology $n Eur Urol $x MED00001669

LZP    __

$a Pubmed-20180709